Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Blue Water Ventures International Inc (OP: BWVI ) 0.0030 -0.0002 (-6.25%) Streaming Delayed Price Updated: 11:12 AM EDT, May 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 10,000 Open 0.0030 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.0032 Today's Range 0.0030 - 0.0030 52wk Range 0.0012 - 0.1890 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Historical Regulatory Filing Deficiences Continue to Stifle Psycheceutical Biosciences May 16, 2024 Via ACCESSWIRE Psychedelics 2024: Veterans Blessing, Mental Health Paradigm Shift, Providers Training, Ketamine-MDMA Bonds & More March 06, 2024 Via Benzinga Performance YTD -95.35% -95.35% 1 Month -78.57% -78.57% 3 Month -90.99% -90.99% 6 Month -95.00% -95.00% 1 Year -97.96% -97.96% More News Read More Podcast - Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: '2024 Is When It Goes Mainstream' February 29, 2024 Via Benzinga Psycheceutical Bioscience Strategically Pivots Into the Brain-Computer Interface (BCI) Space January 17, 2024 Via ACCESSWIRE Dr. Neilank Jha Appointed as Executive Chairman and Chief Executive Officer of Psycheceutical Bioscience Inc. December 12, 2023 Via ACCESSWIRE Shark Tank's Kevin Harrington Leads Crowdfunding Campaign For Psycheceutical Bioscience (OTCPK: BWVI) November 06, 2023 Via Benzinga Psycheceutical Bioscience Launches Wefunder Crowdfunding Campaign for Safer Psychedelic Dosing November 01, 2023 Via ACCESSWIRE Treating PTSD Topically & Directly To The Brain? Psychedelics Delivery Company Poised For Major Breakthrough September 03, 2023 Via Benzinga Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect Ketamine for PTSD August 10, 2023 Via ACCESSWIRE Psycheceutical Bioscience Announces Completion of PCAOB Audit and Future Corporation Action Strategy August 01, 2023 Via ACCESSWIRE First Patient Dosed in Psycheceutical's Phase I Study Exploring Topical Administration of Ketamine to Treat PTSD July 13, 2023 Via ACCESSWIRE Video: 'Moms On Mushrooms Are Gonna Change The Whole Society,' Says Zappy Zapolin Before Presenting Rick Doblin Award June 23, 2023 Via Benzinga EXCLUSIVE: Lessons From Psychedelics Markets Through Business, Legal And Reciprocity Lenses May 12, 2023 Via Benzinga Zappy Zapolin Talks Psychedelics And Breakthrough Delivery Methods: The Future Has Arrived And It's Awesome May 03, 2023 Via Benzinga The Next Generation Of Mental Health Treatment: Psycheceutical Bioscience Inc.’s (OTCPK:BWVI) Novel Topical Ketamine Delivery April 18, 2023 Via ACCESSWIRE Psyched: MDMA Therapy Advances With FDA, Alternatives For Alcohol Addiction, Prince Harry In The Spotlight And More April 11, 2023 Via Benzinga This Groundbreaking Ketamine Topical Cream Is Capturing Rick Doblin's Attention April 05, 2023 Via Benzinga What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry April 03, 2023 Via Benzinga Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its Drug Development Lab March 29, 2023 From Psycheceutical Bioscience, Inc. Via GlobeNewswire What If There Was A Topical Cream That Treated PTSD Without Side Effects? — Psycheceutical Bioscience, Inc (OTCPK: BWVI) Is Pioneering A Possible Solution March 29, 2023 Via News Direct What If There Was A Topical Cream That Treated PTSD Without Side Effects? — Psycheceutical Bioscience, Inc (OTCPK: BWVI) Is Pioneering A Possible Solution March 29, 2023 Via TheNewswire.com Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More March 27, 2023 Via Benzinga Breakthrough Treatment For PTSD? This Ketamine Cream Showing Promise In Alleviating Symptoms March 22, 2023 Via Benzinga Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD March 21, 2023 From Psycheceutical Bioscience, Inc. Via GlobeNewswire Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person March 08, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
